Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: A model for deterring resistance

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 5, 1996, Pages 467-471

  Plowe, Christopher V ^a   Djimde, Abdoulaye ^a   Wellems, Thomas E ^a   Diop, Samba ^a   Kouriba, Bourema ^a   Doumbo, Ogobara K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CHLOROQUINE; DNA; FANSIDAR; FANSIMEF; PROGUANIL; SERINE; THREONINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SMEAR; CHILD; COMMUNITY; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE;

MALIA; PLASMODIUM FALCIPARUM;

EID: 0029842959     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.467     Document Type: Article

References (12)

1. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC. 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
2. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9114-9118.
3. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ, 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85: 9109-9113.
4. Zolg JW, Plitt JR, Chen GX, Palmer S, 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36: 253-262.
5. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of differential resistance to cydoguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
6. Foote SJ, Galatis D, Cowman AF, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
7. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
8. Gyang FN, Peterson DS, Wellems TE. 1992. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Exp Parasitol 74: 470-472.
9. Watkins WM, Mosobo M, 1993. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg 87: 75-78.
10. Snewin VA, Herrera M, Sanchez G, Schef A, Langsley G, Herrera S, 1991. Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia. Mol Biochem Parasitol 49: 265-275.
11. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE, 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
12. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.